Cyrus Biotechnology is a developer of Rosetta software platform that solves drug discovery problems.
Cyrus Biotechnology's investors include Alumni Ventures, OrbiMed, Alexandria Venture Investments, Trinity Ventures, Agent Capital.
Cyrus Biotechnology is headquartered in Seattle, United States.
Cyrus Biotechnology is a developer of Rosetta software platform that solves drug discovery problems.
Cyrus Biotechnology is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cyrus Biotechnology — Funding & Investors." VCBacked, February 26, 2024, https://www.vcbacked.co/company/cyrus-biotechnology. Accessed September 30, 2026.
VCBacked. (2024). Cyrus Biotechnology — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/cyrus-biotechnology
{{cite web |title=Cyrus Biotechnology — Funding & Investors |url=https://www.vcbacked.co/company/cyrus-biotechnology |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated